Application of atrial natriuretic peptide in preparation of medicine for treating inflammatory bowel diseases

An atrial natriuretic peptide, inflammatory bowel disease technology, applied in the field of biomedicine, can solve problems such as inability to use IBD, metabolic disorders, maintenance therapy, etc.

Active Publication Date: 2020-06-12
XIEHE HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI & TECH UNIV
View PDF8 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although glucocorticoids can quickly induce remission and are cheap, but due to the simultaneous regulation of growth, development, metabolism and other physiological functions

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of atrial natriuretic peptide in preparation of medicine for treating inflammatory bowel diseases
  • Application of atrial natriuretic peptide in preparation of medicine for treating inflammatory bowel diseases
  • Application of atrial natriuretic peptide in preparation of medicine for treating inflammatory bowel diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] Example 1 Therapeutic Effect on Mice Ulcerative Colitis

[0020] Material:

[0021] A. Mice: C57BL / 6J breed mice (purchased from Beijing Weitong Lihua Company), bred to 20-22g under SPF environment, about 8 weeks old.

[0022] B. Human atrial natriuretic peptide ANP (purchased from Tocris Bioscience, UK), amino acid sequence Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly - Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr, molecular weight 3080.46 Da; purity 95.8%.

[0023] Method and Results:

[0024] 1. Construction of dextran sodium sulfate (DSS)-induced colitis mouse model and the intervention of ANP recombinant protein.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Molecular weightaaaaaaaaaa
Login to view more

Abstract

The invention relates to application of atrial natriuretic peptide in preparation of a medicine for treating inflammatory bowel diseases. According to the application of the atrial natriuretic peptidein preparation of the medicine for treating inflammatory bowel diseases, the inflammatory bowel diseases comprise ulcerative colitis, Crohn's disease and amorphous colitis. The atrial natriuretic peptide has no adverse effect on normal cells, has no toxic or side effect and can effectively relieve colonic inflammation of colitis and reduce secretion of inflammatory cytokines of colonic tissues.

Description

technical field [0001] The invention belongs to the field of biomedicine, in particular to the application of atrial natriuretic peptide in the preparation of anti-inflammatory drugs. Background technique [0002] Inflammatory bowel disease (IBD) mainly includes ulcerative colitis (UC) and Crohn's disease (CD), the breakthrough of its treatment is inseparable from the development of new drugs. [0003] The main treatment drugs for IBD include 5-aminosalicylic acid, glucocorticoids, immunosuppressants and biologics, which induce and maintain disease remission through immune modulation. In recent years, drug research and development has mainly focused on biological agents and small molecule targeted drugs, but research on hormone drugs is relatively lacking. Although glucocorticoids can quickly induce remission and are cheap, but due to the simultaneous regulation of growth, development, metabolism and other physiological functions, long-term use has many side effects, which ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K38/22A61P1/00A61P29/00A61P1/04
CPCA61K38/2242A61P1/00A61P29/00A61P1/04
Inventor 陈超越付妤全润泽张颖赵溪
Owner XIEHE HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI & TECH UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap